| The role of neuroimaging in Parkinson’s disease NSR Bidesi, I Vang Andersen, AD Windhorst, V Shalgunov, MM Herth Journal of neurochemistry 159 (4), 660-689, 2021 | 108 | 2021 |
| Pretargeted imaging beyond the blood–brain barrier V Shalgunov, SL van den Broek, IV Andersen, RG Vázquez, NR Raval, ... RSC medicinal chemistry 14 (3), 444-453, 2023 | 22 | 2023 |
| Synaptic density and neuronal metabolic function measured by positron emission tomography in the unilateral 6-OHDA rat model of Parkinson’s disease NR Raval, F Gudmundsen, M Juhl, IV Andersen, N Speth, A Videbæk, ... Frontiers in synaptic neuroscience 13, 715811, 2021 | 18 | 2021 |
| Blocking of efflux transporters in rats improves translational validation of brain radioligands V Shalgunov, M Xiong, ET L’Estrade, NR Raval, IV Andersen, FG Edgar, ... EJNMMI research 10, 1-11, 2020 | 14 | 2020 |
| Optimization of Direct Aromatic 18F-Labeling of Tetrazines IV Andersen, R García-Vázquez, UM Battisti, MM Herth Molecules 27 (13), 4022, 2022 | 12 | 2022 |
| A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants N Modhiran, SM Lauer, AA Amarilla, P Hewins, SIL van den Broek, ... Iscience 26 (7), 2023 | 7 | 2023 |
| Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1, 2, 4, 5-tetrazin-3-yl) benzyl) propan-1-amine V Shalgunov, SL van den Broek, IV Andersen, NR Raval, G Schäfer, ... Nuclear Medicine and Biology 128, 108877, 2024 | 2 | 2024 |
| Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein S Lopes van den Broek, R García-Vázquez, IV Andersen, ... Frontiers in Nuclear Medicine 2, 1033697, 2022 | 1 | 2022 |
| Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier V Shalgunov, SL van den Broek, I Andersen, RG Vázquez, N Raval, ... Nuclear Medicine and Biology 108, S103-S104, 2022 | 1 | 2022 |
| Synaptic density and neuronal metabolic function measured by PET in the unilateral 6-OHDA rat model of Parkinson’s disease NR Raval, F Gudmundsen, M Juhl, IV Andersen, NR Speth, A Videbæk, ... bioRxiv, 2021.05. 27.444950, 2021 | 1 | 2021 |
| Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin–A feasibility study using positron emission tomography and [64Cu] Cu-DOTATATE IV Andersen, NSR Bidesi, V Shalgunov, JT Jørgensen, T Gustavsson, ... Nuclear Medicine and Biology 132, 108905, 2024 | | 2024 |
| An alpaca-derived nanobody recognizes a unique conserved epitope and retains potent activity against the SARS-CoV-2 omicron variant N Modhiran, SM Lauer, AA Amarilla, P Hewins, SIL van den Broek, ... bioRxiv, 2022.12. 27.521990, 2022 | | 2022 |
| New way to refine direct aromatic 18F-labeling of tetrazines I Andersen, M Herth, RG Vázquez Nuclear Medicine and Biology 108, S76, 2022 | | 2022 |
| Binding of [64Cu] DOTATATE beyond the BBB I Andersen, M Herth, N Bidesi, A Kjær, V Shalgunov, J Jørgensen, ... Nuclear Medicine and Biology 108, S172-S173, 2022 | | 2022 |
| An alpaca-derived nanobody neutralizes the SARS-CoV-2 omicron variant (preprint) N Modhiran, SM Lauer, AA Amarilla, P Hewins, SIL van den Broek, ... | | 2022 |
| Optimisation attempts for the direct nucleophilic 18F-labelling of tetrazines I Andersen Journal of Nuclear Medicine 61 (supplement 1), 1101-1101, 2020 | | 2020 |
| RSC Medicinal Chemistry L van den Broek, IV Andersen, R García-Vázquez, NR Raval, M Palner, ... | | |
| Blocking of E ux Transporters in Rats Improves Translational Validation of Brain Radioligands V Shalgunov, M Xiong, E T L'Estrade, NR Raval, IV Andersen, FG Edgar, ... | | |
